X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/09/2756594/0/en/RAD-receives-approval-for-Phase-1-therapeutic-study-of-PDL1-nanobody-in-Non-Small-Cell-Lung-Cancer.html
https://www.globenewswire.com//news-release/2023/08/24/2731100/0/en/Radiopharm-Theranostics-Expands-Supply-Agreement-With-TerThera-for-Terbium-161-Isotope-Use-in-Prostate-Cancer.html
https://www.globenewswire.com/news-release/2023/05/09/2664296/0/en/Radiopharm-Theranostics-Receives-FDA-Orphan-Drug-Designation-for-Trivehexin-RAD-301-in-Pancreatic-Cancer.html
https://www.globenewswire.com/news-release/2023/04/17/2647815/0/en/Radiopharm-Theranostics-Enters-Into-Supply-Agreement-with-TerThera-for-Terbium-161-Isotope.html
https://www.globenewswire.com/news-release/2023/03/28/2635541/0/en/Radiopharm-Theranostics-Invited-to-Participate-in-Jefferies-Radiopharma-Innovation-Summit.html
https://www.globenewswire.com/news-release/2023/03/03/2620158/0/en/Dr-Ken-Herrmann-Appointed-to-RAD-Scientific-Advisory-Board.html
https://www.globenewswire.com/news-release/2023/03/03/2620252/0/en/Radiopharm-Theranostics-Partners-With-Next-Generation-Preclinical-Platform-for-Therapeutic-Radiopharmaceuticals.html
https://www.globenewswire.com/news-release/2023/02/14/2607567/0/en/Radiopharm-Theranostics-Initiates-Process-for-Nasdaq-Listing.html
Market Place
Share 
